Products in wound management span simple dressings and bandages to advanced biotech, mechanical and other technologies designed to facilitate and accelerate the wound healing process.  The combined nature of the resulting product market -- from well established high volume sectors to rapid growth emerging sectors -- represents enormous business potential for current and prospective wound management companies.

FOOTHILL RANCH, CA --- MedMarket Diligence is publishing (November 2007) a market and technology business report on the worldwide market for products in wound management.  An excerpt from the October edition of MedMarkets, drawn from the forthcoming report, puts the wound management market potential in perspective:

The size of the worldwide wound management market is ultimately driven by the clinical need for advanced wound management products. That need is most clearly reflected in the prevalence of chronic wounds and burns. Current estimates put the total annual incidence of chronic wounds at almost 9 million worldwide. A portion of these are accounted for by the 177 million cases of diabetes worldwide; 10%–15% of diabetic patients will develop ulcers at some point. The market for products used in the management of venous stasis (as in chronic venous ulcers) is estimated to surpass $3 billion, while the decubitus ulcer (e.g., bedsores) market is in excess of $2 billion. Sales of products used to treat diabetic foot ulcers are estimated around $1.5 billion, and the market for burn dressings is approximately $60 million.

The MedMarket Diligence report, "Worldwide Wound Management, 2007-2016" details the current and projected market for wound management products, including dressings, closure devices, debridement, pharmacological products, tissue engineered products and others. Particular emphasis is placed on advanced and leading edge developments (i.e., those approaching wound management from novel perspective) such as growth factors, stem cells, gene therapy and other approaches, while baseline data (current and forecast market size and current competitor market shares) is provided for established segments -- multiple dressings types (film, foam, alginate, antibacterial, non-adherent), hydrogels, hydrocolloids, pharmaceuticals, and physical treatments.

The report details the clinical and technology developments underlying this huge and evolving worldwide market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity.  Separate size, growth and competitor data are presented for the U.S., leading western European countries, Japan and the Rest of World category.  The report profiles leading and emerging companies, with profiles providing detailed profile information on major competitors, brief profiles of companies with less sizeable current or potential positions in the market, and additional profiles of companies with novel or advanced research activities in the market.

The report is described in detail, with a working table of contents, at http://www.mediligence.com/rpt/rpt-s245.htm.

The report can be purchased directly online.

For additional information, contact Patrick Driscoll, at (949) 859-3401, or patrick {at} mediligence {dot} com.

About MedMarket Diligence
MedMarket Diligence provides tactical decision-making solutions on medical technology to the medical products and investment industries. The company publishes the MedMarkets newsletter, a monthly analysis of the market implications of new medical technologies, dedicated Reports on technology markets and the Medtech Startups Database. 

© 2001- MedMarket Diligence, LLC.  All rights reserved.